INTRODUCTION:

C. Warren Olanow

Prospects for neuroprotection in Parkinson’s disease
Neurology 2006 66: S1. [Full Text]  

ARTICLES:

Werner Poewe

The need for neuroprotective therapies in Parkinson’s disease: A clinical perspective
Neurology 2006 66: S2-9. [Abstract] [Full Text]  

Anthony H.V. Schapira

Etiology of Parkinson’s disease
Neurology 2006 66: S10-23. [Abstract] [Full Text]  

Peter Jenner and C. Warren Olanow

The pathogenesis of cell death in Parkinson's disease
Neurology 2006 66: S24-36. [Abstract] [Full Text]  

Kevin St. P. McNaught, Tehone Jackson, Ruth JnoBaptiste, Alexander Kapustin, and C. Warren Olanow

Proteasomal dysfunction in sporadic Parkinson's disease
Neurology 2006 66: S37-49. [Abstract] [Full Text] [Figures Only]  

Karl Kieburtz

Issues in neuroprotection clinical trials in Parkinson’s disease
Neurology 2006 66: S50-57. [Abstract] [Full Text]  

Robert A. Hauser and Theresa A. Zesiewicz

Clinical trials aimed at detecting neuroprotection in Parkinson’s disease
Neurology 2006 66: S58-68. [Abstract] [Full Text]  

C. Warren Olanow

Rationale for considering that propargylamines might be neuroprotective in Parkinson’s disease
Neurology 2006 66: S69-79. [Abstract] [Full Text] [Figures Only]  

Andrew Siderowf and Matthew Stern

Clinical trials with rasagiline: Evidence for short-term and long-term effects
Neurology 2006 66: S80-88. [Abstract] [Full Text] [Figures Only]  

Biplob Dass, C. Warren Olanow, and Jeffrey H. Kordower

Gene transfer of trophic factors and stem cell grafting as treatments for Parkinson’s disease
Neurology 2006 66: S89-103. [Abstract] [Full Text] [Figures Only]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.